EXOZYMES INC. — Director's Dealing 2024

Nov 19, 2024

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Invizyne Technologies Inc (IZTC)
CIK: 0002010788
Period of Report: 2024-11-08

Reporting Person: Lalonde James Joseph (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options for Common Stock	$2.44	2028-01-31	Common Stock (7791)		Direct
Stock Options for Common Stock	$8.00	2031-03-31	Common Stock (51939)		Direct

Footnotes

F1: The options vest as follows: The first 130 shares vest per month starting February 1, 2021, and the balance vest at monthly basis thereafter, and become exercisable once vested. All shares are vested by 01/31/2026.

F2: The options vest as follows: The first 2,597 shares vest on July 1, 2024, and the balance vest at the rate of 2,597 shares per quarter, commencing on October 1, 2024, and become exercisable once vested. All shares are vested by 03/31/2029.